Comment
. 2004 Sep;364(9438):932; author reply 935.
doi: 10.1016/S0140-6736(04)17011-6.
VALUE: analysis of results
- PMID: 15364178
- DOI: 10.1016/S0140-6736(04)17011-6
Item in Clipboard
Comment
VALUE: analysis of results
Lancet.
2004 Sep.
No abstract available
Comment on
-
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial.Lancet. 2004 Jun 19;363(9426):2022-31. doi: 10.1016/S0140-6736(04)16451-9. Lancet. 2004. PMID: 15207952 Clinical Trial.
Similar articles
-
VALUE: analysis of results.Lancet. 2004 Sep 11-17;364(9438):934-5; author reply 935. doi: 10.1016/S0140-6736(04)17015-3. Lancet. 2004. PMID: 15364181 No abstract available.
-
Valsartan treatment of hypertension--does VALUE add value?Lancet. 2004 Jun 19;363(9426):2010-1. doi: 10.1016/S0140-6736(04)16484-2. Lancet. 2004. PMID: 15207946 No abstract available.
-
[Risk oriented therapy of hypertension. Lowering blood pressure and risk].MMW Fortschr Med. 2007 Nov 15;149(46):53. MMW Fortschr Med. 2007. PMID: 18069196 German. No abstract available.
-
Single-pill combination of amlodipine and valsartan in the management of hypertension.Expert Opin Pharmacother. 2009 Aug;10(12):1979-94. doi: 10.1517/14656560903120899. Expert Opin Pharmacother. 2009. PMID: 19606937 Review.
-
[VALUE].Nihon Rinsho. 2006 Aug;64 Suppl 6:419-24. Nihon Rinsho. 2006. PMID: 16981573 Review. Japanese. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
